Literature DB >> 578622

Thyroid vascularity--documentation of the iodide effect in thyrotoxicosis.

B E Brownlie, J G Turner, M A Ellwood, T G Rogers, D I Armstrong.   

Abstract

Thyroid vascularity was measured in 101 thyrotoxic patients by analysis of 99mTc pertechnetate thyroid flow studies obtained with a gamma camera--minicomputer system. The diffusely hyperplastic goitres tended to have higher vascularity than the toxic multinodular goitres, and many of the solitary toxic nodules had vascularity results within normal limits. Potassium iodide therapy, 60 mg b.d. for 10-14 days results in a dramatic reduction in thyroid vascularity in diffuse thyroid hyperplasia and toxic multinodular goitre but the effect on toxic nodules was marginal.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 578622     DOI: 10.1530/acta.0.0860317

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  6 in total

1.  Duplex scan-derived thyroid blood flow in euthyroid and hyperthyroid patients.

Authors:  K J Hodgson; J H Lazarus; M H Wheeler; J P Woodcock; G M Owen; A M McGregor; R Hall
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

2.  Thyroidectomy: is Lugol's iodine necessary?

Authors: 
Journal:  Ann R Coll Surg Engl       Date:  1983-01       Impact factor: 1.891

3.  Thyroid disease: recognition and management.

Authors:  B E Brownlie
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

Review 4.  Biochemistry of thyroid regulation under normal and abnormal conditions.

Authors:  M A Pisarev; D L Kleiman de Pisarev
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

5.  Thyroid blood flow rate in man. Electromagnetic flowmetry during operation in euthyroid normal gland, nontoxic goiter, and hyperthyroidism.

Authors:  L Tegler; J Gillquist; B Anderberg; B Lundström; H Johansson
Journal:  J Endocrinol Invest       Date:  1981 Jul-Sep       Impact factor: 4.256

Review 6.  Lugol's solution and other iodide preparations: perspectives and research directions in Graves' disease.

Authors:  Jan Calissendorff; Henrik Falhammar
Journal:  Endocrine       Date:  2017-10-26       Impact factor: 3.633

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.